Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:36 pm Unchanged | 2021-12-31 | 13G | Matterport, Inc. MTTR | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 5:27 pm Sale | 2021-12-31 | 13G | TPG Pace Beneficial Finance Corp. TPGY | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -2,075,000 (Position Closed) | Filing History |
| 2022-02-11 5:25 pm Purchase | 2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,638,775 7.200% | 586,417 (+28.57%) | Filing History |
| 2022-02-11 5:20 pm Purchase | 2021-12-31 | 13G | Solid Biosciences Inc. SLDB | SUVRETTA CAPITAL MANAGEMENT LLC | 419,146 5.700% | 20,867 (+5.24%) | Filing History |
| 2022-02-11 5:17 pm Purchase | 2021-12-31 | 13G | POINT Biopharma Global Inc. PNT | SUVRETTA CAPITAL MANAGEMENT LLC | 2,672,863 3.000% | 2,672,863 (New Position) | Filing History |
| 2022-02-11 5:14 pm Sale | 2021-12-31 | 13G | Fintech Acquisition Corp. V FTCV | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -1,901,890 (Position Closed) | Filing History |
| 2022-02-11 5:09 pm Sale | 2021-12-31 | 13G | Otonomy, Inc. OTIC | SUVRETTA CAPITAL MANAGEMENT LLC | 5,993,689 9.990% | -25,189 (-0.42%) | Filing History |
| 2022-02-11 5:09 pm Unchanged | 2021-12-31 | 13G | Berkshire Grey, Inc. BGRY | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 5:03 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,746,300 7.100% | 449,848 (+34.70%) | Filing History |
| 2022-02-11 4:55 pm Purchase | 2021-12-31 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 3,572,419 5.400% | 69,000 (+1.97%) | Filing History |
| 2022-02-11 4:55 pm Sale | 2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0.000% | -383,880 (Position Closed) | Filing History |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 247,380 5.400% | 6,540 (+2.72%) | Filing History |
| 2022-02-11 4:47 pm Purchase | 2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 237,227 5.500% | 13,942 (+6.24%) | Filing History |
| 2022-02-11 4:45 pm Purchase | 2021-12-31 | 13G | Sio Gene Therapies Inc. SIOX | SUVRETTA CAPITAL MANAGEMENT LLC | 5,914,000 8.100% | 425,000 (+7.74%) | Filing History |
| 2022-02-11 4:38 pm Purchase | 2021-12-31 | 13G | Cano Health, Inc. CANO | SUVRETTA CAPITAL MANAGEMENT LLC | 105,476 5.800% | 18,387 (+21.11%) | Filing History |
| 2022-02-11 4:37 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 45,710,335 8.400% | 13,882,835 (+43.62%) | Filing History |
| 2022-02-11 4:24 pm Purchase | 2021-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 3,482,109 9.990% | 1,886,945 (+118.29%) | Filing History |
| 2022-02-11 4:19 pm Purchase | 2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 2,375,571 5.900% | 578,653 (+32.20%) | Filing History |
| 2021-12-16 4:32 pm Purchase | 2021-12-06 | 13G | Aeglea BioTherapeutics, Inc. AGLE | SUVRETTA CAPITAL MANAGEMENT LLC | 102,840 5.200% | 102,840 (New Position) | Filing History |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | Sutro Biopharma, Inc. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 240,840 5.200% | 240,840 (New Position) | Filing History |